Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Portola's Supplementary Approval Paves Way For Belated Bevyxxa Launch

Dec 19 2017

• By Emily Hayes

FDA approved background, 3D rendering, blue street sign

Related Content

Portola's Bevyxxa Poised To Capture Niche Novel Anticoagulant Market

Jun 26 2017

Portola's AndexXa Antidote For Xarelto And Eliquis Finally On The Way

Aug 16 2017

Related Companies

Portola Pharmaceuticals, Inc.

Johnson & Johnson

Bayer AG

Bristol Myers Squibb Company

Pfizer Inc.

Boehringer Ingelheim GmbH

Daiichi Sankyo Co., Ltd.

Additional Topics

Approvals Manufacturing FDA Cardiovascular BioPharmaceutical

More from New Products

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window